Strand Life Sciences Develops Prenatal Genomic Diagnostics Portfolio
April 23, 2024 18:25Strand Life Sciences, a subsidiary of Reliance Industries Ltd., and a leading global provider of genomic and bioinformatic solutions, has made two breakthrough technologies in its prenatal screening and diagnostics portfolio: CNSeq (for identification of aneuploidies and copy number variations) and MaatriSeq (Non-Invasive Prenatal Screening). These innovations are tailored to the specific needs of the […]









